Singh O, Avinash P, Gautam A, Prasad A, Jagawat T
Indian J Psychiatry. 2025; 67(1):98-105.
PMID: 40046482
PMC: 11878465.
DOI: 10.4103/indianjpsychiatry.indianjpsychiatry_563_24.
Oudega M, Wagenmakers M, Palsma T, Hoogendoorn A, Vriend C, van den Heuvel O
Front Psychiatry. 2025; 15():1509821.
PMID: 39822386
PMC: 11735943.
DOI: 10.3389/fpsyt.2024.1509821.
Bustamante L, Barch D, Solis J, Oshinowo T, Grahek I, Konova A
Psychol Med. 2024; :1-12.
PMID: 39618329
PMC: 11650159.
DOI: 10.1017/S0033291724002691.
Kasselman L, Peltier M, Leon J, Reiss A
Nutrients. 2024; 16(21).
PMID: 39519464
PMC: 11547479.
DOI: 10.3390/nu16213631.
Bienek O, Allott K, Antonucci L, Bertolino A, Bonivento C, Borgwardt S
Eur Child Adolesc Psychiatry. 2024; .
PMID: 39503777
DOI: 10.1007/s00787-024-02599-0.
Sleep disturbances and psychomotor retardation in the prediction of cognitive impairments in patients with major depressive disorder.
Wang M, Chen W, Wang H, Liu B, Ju Y, Dong Q
World J Psychiatry. 2024; 14(10):1474-1483.
PMID: 39474372
PMC: 11514569.
DOI: 10.5498/wjp.v14.i10.1474.
Major Depression in Comorbidity with Substance use Disorders: Patients' Features and Clinical-Neurobiological Rationale of Antidepressant Treatments.
De Filippis S, Martinotti G, Nicoletti F, Mastrostefano A, Trovini G, Pugliese A
Curr Neuropharmacol. 2024; 23(3):256-275.
PMID: 39219428
PMC: 11808588.
DOI: 10.2174/1570159X22666240827165327.
Major depression symptom severity associations with willingness to exert effort and patch foraging strategy.
Bustamante L, Barch D, Solis J, Oshinowo T, Grahek I, Konova A
medRxiv. 2024; .
PMID: 38947009
PMC: 11213125.
DOI: 10.1101/2024.02.18.24302985.
Relationship between cognitive function and functional outcomes in remitted major depression.
Luo R, Fan N, Dou Y, Wang Y, Wang M, Yang X
BMC Psychiatry. 2024; 24(1):311.
PMID: 38658936
PMC: 11040809.
DOI: 10.1186/s12888-024-05675-6.
Assessing remission in major depressive disorder using a functional-structural data fusion pipeline: A CAN-BIND-1 study.
Ayyash S, Davis A, Alders G, MacQueen G, Strother S, Hassel S
IBRO Neurosci Rep. 2024; 16:135-146.
PMID: 38293679
PMC: 10826332.
DOI: 10.1016/j.ibneur.2023.12.011.
Effect of immersive virtual reality-based cognitive remediation in patients with mood or psychosis spectrum disorders: study protocol for a randomized, controlled, double-blinded trial.
Jespersen A, Lumbye A, Vinberg M, Glenthoj L, Nordentoft M, Waehrens E
Trials. 2024; 25(1):82.
PMID: 38268043
PMC: 10809611.
DOI: 10.1186/s13063-024-07910-7.
Comparing the efficacies of transcranial magnetic stimulation treatments using different targeting methods in major depressive disorder: protocol for a network meta-analysis.
Wang S, Kong G, Wu G, Cui H, Qian Z, Xu L
BMJ Open. 2023; 13(12):e075525.
PMID: 38086594
PMC: 10729247.
DOI: 10.1136/bmjopen-2023-075525.
Altered brain functional network topology in Obsessive-Compulsive Disorder: A comparison of patients with varying severity of depressive symptoms and the impact on psychosocial functioning.
Xu Z, Xie M, Wang Z, Chen H, Zhang X, Li W
Neuroimage Clin. 2023; 40:103545.
PMID: 38006651
PMC: 10755823.
DOI: 10.1016/j.nicl.2023.103545.
Deficits in specific executive functions manifest by severity in major depressive disorder: a comparison of antidepressant naïve inpatient, outpatient, subclinical, and healthy control groups.
Malekizadeh H, Saed O, Rashtbari A, Sajjadi M, Ahmadi D, Ronold E
Front Psychiatry. 2023; 14:1225062.
PMID: 37854445
PMC: 10580982.
DOI: 10.3389/fpsyt.2023.1225062.
The Mediating Role of Depression in the Association Between Hearing Impairment and Functional Disability Among Middle-Aged and Older Adults in China.
Han D, Li S, Wu Y, Zhao J, Zhang M, Liao H
Innov Aging. 2023; 7(8):igad093.
PMID: 37841577
PMC: 10573731.
DOI: 10.1093/geroni/igad093.
Low thalamic activity during a digit-symbol substitution task is associated with symptoms of subjective cognitive decline.
Mizuno A, Karim H, Ly M, Lopresti B, Cohen A, Ali A
Front Psychiatry. 2023; 14:1242822.
PMID: 37743995
PMC: 10511647.
DOI: 10.3389/fpsyt.2023.1242822.
Impact of stress on excitatory and inhibitory markers of adolescent cognitive critical period plasticity.
Perica M, Luna B
Neurosci Biobehav Rev. 2023; 153:105378.
PMID: 37643681
PMC: 10591935.
DOI: 10.1016/j.neubiorev.2023.105378.
Antidepressant mechanisms of ketamine: a review of actions with relevance to treatment-resistance and neuroprogression.
Lullau A, Haga E, Ronold E, Dwyer G
Front Neurosci. 2023; 17:1223145.
PMID: 37614344
PMC: 10442706.
DOI: 10.3389/fnins.2023.1223145.
Cognitive outcomes of transcranial magnetic stimulation in treatment-resistant depression: a randomized controlled study.
Yildiz T, Oguzhanoglu N, Topak O
Turk J Med Sci. 2023; 53(1):253-263.
PMID: 36945926
PMC: 10387879.
DOI: 10.55730/1300-0144.5580.
Trajectories of Efficacy and Cognitive Function During Electroconvulsive Therapy Course in Young Adults with Treatment-Resistant Depression.
Xu S, Xie X, Yao L, Chen L, Wan Q, Chen Z
Neuropsychiatr Dis Treat. 2023; 19:267-281.
PMID: 36744206
PMC: 9893845.
DOI: 10.2147/NDT.S394155.